Probiotics are live microorganisms added to food to remain active in the intestine and exert important physiological effects. Ingested in sufficient quantities, can have beneficial effects, such as contributing to the balance of the intestinal microbiota of a host and enhance the immune system. Probiotics for IBS can pass through the digestive tract and feces recovered alive, but also adhere to the intestinal mucosa. They are not pathogenic, except in cases where immunocompromised individuals are supplied.
It is also seen that some foods and probiotic supplements modulate the inflammatory response, and it is thought that this is due at least in part in the regulation of the function of cytokines with regard to the inflammatory response, for example, some clinical studies suggest that they can prevent relapse of inflammatory bowel disease (IBD, inflammatory bowel Disease) in adults.
Lactic acid bacteria (LAB) for the most part represented by lactobacilli, and bifidobacteria are the most common types of probiotic microorganisms, including some yeasts and bacilli may be useful. The lactic acid bacteria are commonly consumed along with the fermented foods that contain them - foods such as yogurt or soy yogurt with the addition of specific bacterial cultures alive and active.
But the two enzymes present in such products do not play a beneficial role in human organisms because they die as soon as they come into contact with the gastric juices. According to FAO / WHO guidelines, good bacteria are defined only those microorganisms that can demonstrate, when ingested in adequate amounts, exert beneficial functions in body.
Probacterias can be used as addition in food (this also includes food, food supplements or dietary foods) or be administered in form of drugs. They are accrued by the prebiotics that have a positive effect (growth stimulation) on already in intestines are in dividend microorganisms and synbiotics, a combination of both. The first observations on the positive effects of probiotics on human health date back to the early twentieth century.
There is broad consensus that some probiotics can improve the quality of life of those suffering from gastrointestinal disorders (bloating, abdominal pain, etc.). Within this population, the group of people who suffer from Irritable Bowel Syndrome (IBS) has been taken as a reference (even for assessments by EFSA) to test the potential of probiotics in improving symptoms.
A probiotic strain widely studied in this context is that the Lactobacillus rhamnosus GG was able to reduce the duration of infectious diarrhea supported by rotavirus, common pathogen in children and an important cause of hospitalization. The guidelines of the American Academy of Pediatrics 2010, as in 2008 the guidelines (Society for Paediatric Gastroenterology, Hepatology and Nutrition) indicate that for the treatment of acute diarrhea the beneficial effect is strain-dependent and that Lactobacillus GG is to date the most effective probiotic, which already if administered at onset of acute diarrhea, is able to reduce the duration of about 1 day.
Lactic acid bacteria are considered useful in the treatment of Helicobacter infections pylor i (associated with peptic ulcers) in adults in combination with medications normally used for this purpose. However, further studies are needed in this area. As of May 2011, there were approximately 140 published studies involving probiotics and H. Pylori, which showed that the addition of probiotic yogurt containing triple eradication therapy did not increase the rate of eradication of H. Pylori, however, reduced the frequency of stomatitis and constipation.
It is also seen that some foods and probiotic supplements modulate the inflammatory response, and it is thought that this is due at least in part in the regulation of the function of cytokines with regard to the inflammatory response, for example, some clinical studies suggest that they can prevent relapse of inflammatory bowel disease (IBD, inflammatory bowel Disease) in adults.
Lactic acid bacteria (LAB) for the most part represented by lactobacilli, and bifidobacteria are the most common types of probiotic microorganisms, including some yeasts and bacilli may be useful. The lactic acid bacteria are commonly consumed along with the fermented foods that contain them - foods such as yogurt or soy yogurt with the addition of specific bacterial cultures alive and active.
But the two enzymes present in such products do not play a beneficial role in human organisms because they die as soon as they come into contact with the gastric juices. According to FAO / WHO guidelines, good bacteria are defined only those microorganisms that can demonstrate, when ingested in adequate amounts, exert beneficial functions in body.
Probacterias can be used as addition in food (this also includes food, food supplements or dietary foods) or be administered in form of drugs. They are accrued by the prebiotics that have a positive effect (growth stimulation) on already in intestines are in dividend microorganisms and synbiotics, a combination of both. The first observations on the positive effects of probiotics on human health date back to the early twentieth century.
There is broad consensus that some probiotics can improve the quality of life of those suffering from gastrointestinal disorders (bloating, abdominal pain, etc.). Within this population, the group of people who suffer from Irritable Bowel Syndrome (IBS) has been taken as a reference (even for assessments by EFSA) to test the potential of probiotics in improving symptoms.
A probiotic strain widely studied in this context is that the Lactobacillus rhamnosus GG was able to reduce the duration of infectious diarrhea supported by rotavirus, common pathogen in children and an important cause of hospitalization. The guidelines of the American Academy of Pediatrics 2010, as in 2008 the guidelines (Society for Paediatric Gastroenterology, Hepatology and Nutrition) indicate that for the treatment of acute diarrhea the beneficial effect is strain-dependent and that Lactobacillus GG is to date the most effective probiotic, which already if administered at onset of acute diarrhea, is able to reduce the duration of about 1 day.
Lactic acid bacteria are considered useful in the treatment of Helicobacter infections pylor i (associated with peptic ulcers) in adults in combination with medications normally used for this purpose. However, further studies are needed in this area. As of May 2011, there were approximately 140 published studies involving probiotics and H. Pylori, which showed that the addition of probiotic yogurt containing triple eradication therapy did not increase the rate of eradication of H. Pylori, however, reduced the frequency of stomatitis and constipation.
No comments:
Post a Comment